Richard A. McClendon

Richard McClendon practices at Capitol Primary Care in Washington, District of Columbia.

Richard McClendon's NPI, 1467574038, was assigned on April 4, 2007. Richard McClendon holds District of Columbia license MD31412.

Richard McClendon's primary practice is Capitol Primary Care, at 1331 H Nw St, Washington, DC 20005 in District Of Columbia County. The practice phone is (202) 810-7822.

Richard McClendon's primary practice is Capitol Primary Care in Washington, District of Columbia. The medical group on file is Mary's Center. Dmand AI also links Richard McClendon to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Richard McClendon practices. Vendor and product names are available with a free account.

Internal medicine is Richard McClendon's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Richard McClendon is licensed in District of Columbia.

CMS data shows 66 Medicare services from Richard McClendon across 2 procedure codes in 2020, for 16 Medicare patients. Medicare paid $385 for them. Every service was in an office.

CMS counts 16 Medicare patients who saw Richard McClendon in 2024. The largest group is 85 and over, with 0 patients. 75% of them have high blood pressure. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Richard McClendon's median patient age at 36, with 35% women.

In 2024, Richard McClendon wrote 709 Medicare Part D claims for 75 patients. 79% of them were for generic drugs. CMS names the drug for 422 of them, across 19 drugs with 11 or more claims each, at $118,580 in total drug cost. In 2023, CMS named 474 claims across 19 drugs.

Richard McClendon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Richard McClendon as offering telehealth.

CMS Open Payments shows 18 general payments to Richard McClendon from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $991.